Mikael Dolsten

(Dr. Mikael Dolsten M.D., Ph.D.)

Currently holds positions in Pfizer Inc and Karyopharm Therapeutics Inc

Positions
Position Company Period
Chief Scientific Officer, President - Worldwide Research, Development and Medical Pfizer Inc Jan. 1, 2019 -
Independent Director Karyopharm Therapeutics Inc Jan. 1, 2017 -
President - Worldwide Research and Development Pfizer Inc Dec. 1, 2010 - Jan. 1, 2019
Director Karyopharm Therapeutics Inc March 31, 2015 - Jan. 1, 2017
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-05-12 2022-05-11
US Pfizer Inc (PFE)
S Sale
32,015 -8.8%
49.31
1,578,660 USD 		32,015 -8.8% 49.31 1,578,660 USD
2022-05-12 2022-05-11
US Pfizer Inc (PFE)
S Sale
18,562 -4.8%
49.32
915,478 USD 		18,562 -4.8% 49.32 915,478 USD
2022-05-12 2022-05-11
US Pfizer Inc (PFE)
S Sale
7,876 -2.0%
49.33
388,523 USD 		7,876 -2.0% 49.33 388,523 USD
2022-05-12 2022-05-11
US Pfizer Inc (PFE)
S Sale
2,891 -0.7%
49.35
142,671 USD 		2,891 -0.7% 49.35 142,671 USD
2022-05-12 2022-05-11
US Pfizer Inc (PFE)
S Sale
2,358 -0.6%
49.34
116,344 USD 		2,358 -0.6% 49.34 116,344 USD
2022-05-12 2022-05-11
US Pfizer Inc (PFE)
S Sale
200 -0.1%
49.36
9,872 USD 		200 -0.1% 49.36 9,872 USD
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
36,711 -11.6%
50.28
1,845,829 USD 		36,711 -11.6% 50.28 1,845,829 USD
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
6,708 -2.1%
50.33
337,614 USD 		6,708 -2.1% 50.33 337,614 USD
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
5,227 -1.6%
50.29
262,866 USD 		5,227 -1.6% 50.29 262,866 USD
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
3,396 -1.0%
50.31
170,853 USD 		3,396 -1.0% 50.31 170,853 USD
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
3,197 -1.0%
50.29
160,777 USD 		3,197 -1.0% 50.29 160,777 USD
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
2,301 -0.7%
50.32
115,786 USD 		2,301 -0.7% 50.32 115,786 USD
2021-11-15 2021-11-11
US Pfizer Inc (PFE)
S Sale
2,124 -0.6%
50.34
106,922 USD 		2,124 -0.6% 50.34 106,922 USD
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
24,242 -12.2%
37.79
916,105 USD 		24,242 -12.2% 37.79 916,105 USD
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
17,357 -8.0%
37.78
655,747 USD 		17,357 -8.0% 37.78 655,747 USD
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
16,840 -7.2%
37.80
636,552 USD 		16,840 -7.2% 37.80 636,552 USD
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
14,727 -5.9%
37.77
556,239 USD 		14,727 -5.9% 37.77 556,239 USD
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
9,700 -3.8%
37.75
366,175 USD 		9,700 -3.8% 37.75 366,175 USD
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
6,470 -2.4%
37.81
244,631 USD 		6,470 -2.4% 37.81 244,631 USD
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
5,517 -2.0%
37.76
208,322 USD 		5,517 -2.0% 37.76 208,322 USD
2020-05-19 2020-05-18
US Pfizer Inc (PFE)
S Sale
500 -0.2%
37.82
18,910 USD 		500 -0.2% 37.82 18,910 USD
2019-03-05 2019-03-04
US Pfizer Inc (PFE)
S Sale
38,645 -11.8%
43.52
1,681,830 USD 		38,645 -11.8% 43.52 1,681,830 USD
2019-03-05 2019-03-04
US Pfizer Inc (PFE)
S Sale
3,250 -1.0%
43.53
141,473 USD 		3,250 -1.0% 43.53 141,473 USD
2019-03-05 2019-03-04
US Pfizer Inc (PFE)
S Sale
2,600 -0.8%
43.54
113,204 USD 		2,600 -0.8% 43.54 113,204 USD
2019-03-05 2019-03-04
US Pfizer Inc (PFE)
S Sale
2,400 -0.7%
43.55
104,520 USD 		2,400 -0.7% 43.55 104,520 USD
2019-03-05 2019-03-04
US Pfizer Inc (PFE)
S Sale
2,187 -0.6%
43.56
95,266 USD 		2,187 -0.6% 43.56 95,266 USD
2019-03-05 2019-03-01
US Pfizer Inc (PFE)
S Sale
77,484 -18.6%
43.56
3,375,203 USD 		77,484 -18.6% 43.56 3,375,203 USD
2019-03-05 2019-03-01
US Pfizer Inc (PFE)
S Sale
14,760 -3.4%
43.57
643,093 USD 		14,760 -3.4% 43.57 643,093 USD
2019-03-05 2019-03-01
US Pfizer Inc (PFE)
S Sale
5,927 -1.4%
43.58
258,299 USD 		5,927 -1.4% 43.58 258,299 USD
2019-03-05 2019-03-01
US Pfizer Inc (PFE)
S Sale
2,300 -0.5%
43.59
100,257 USD 		2,300 -0.5% 43.59 100,257 USD